New Study: Tramadol Offers Minimal Relief, Raises Heart Risks

A new comprehensive study published in BMJ Evidence-Based Medicine reveals that the common painkiller Tramadol provides only minimal pain relief for chronic conditions. The analysis indicates it significantly doubles the risk of serious adverse events, predominantly cardiovascular issues like heart failure, challenging its perception as a safer opioid option.

• Tramadol's pain relief is minimal, often below clinical significance.
• Study links Tramadol to double the risk of serious adverse events.
• Primary serious risks include chest pain, coronary artery disease, heart failure.
• Common side effects are nausea, dizziness, constipation, and sleepiness.
• Researchers recommend minimizing Tramadol use as harms outweigh benefits.
• The findings challenge Tramadol's perception as a safer opioid alternative.

Read the full story on Quick Digest.